本页面由Tiger Trade Technology Pte. Ltd.提供服务

Teladoc Health Inc.

7.46
-0.1500-1.97%
盘前7.39-0.0700-0.94%04:12 EST
成交量:499.74万
成交额:3,721.10万
市值:13.24亿
市盈率:-5.84
高:7.78
开:7.72
低:7.36
收:7.61
52周最高:15.21
52周最低:6.35
股本:1.77亿
流通股本:1.75亿
量比:0.93
换手率:2.86%
股息:- -
股息率:- -
每股收益(TTM):-1.2780
每股收益(LYR):-5.8702
净资产收益率:-15.42%
总资产收益率:-3.48%
市净率:0.95
市盈率(LYR):-1.27

数据加载中...

2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/23

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities